Zhimin Zhai

7PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 14, 2026
Targeting CD74 may mitigate immune-escape features and enhance BCMA CAR-T activity in preclinical models of relapsed/refractory multiple myeloma.

|Jan 08, 2025
Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin's lymphoma via CCR7/ARHGAP18/IKBα signaling activation.

Jiyu Wang, Qianshan Tao, Keke Huang

|Sep 06, 2024
Immune isolation-enabled nanoencapsulation of donor T cells: a promising strategy for mitigating GVHD and treating AML in preclinical models.

Dan Mei, Ziyang Xue, Tianjing Zhang

|Aug 15, 2022
A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma.

Hua Wang, Bi-Bo Fu, Zhi-Jun Wuxiao

|Aug 15, 2022
Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia

Xiyang Ren, Qianshan Tao, Huiping Wang

|Nov 24, 2020
Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia.

Furun An, Huiping Wang, Zhenyun Liu

Pageof 2

Frequent Collaborators

4 joint publications

Huiping Wang

3 joint publications

Fan Wu

2 joint publications

Zhitao Wang

2 joint publications

Qing Zhang